A phase ii trial of oral estramustine and oral etoposide in hormone refractory prostate cancer
- 30 September 1997
- Vol. 50 (3) , 401-407
- https://doi.org/10.1016/s0090-4295(97)00228-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancer.Journal of Clinical Oncology, 1995
- Inhibition of prostate cancer growth by estramustine and colchicineThe Prostate, 1995
- Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987Urology, 1995
- Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.Journal of Clinical Oncology, 1994
- Combination chemotherapy in advanced prostate cancer: a silk purse?Journal of Clinical Oncology, 1994
- Oral Cyclophosphamide for the Management of Hormone‐refractory Prostate CancerBritish Journal of Urology, 1993
- Risk Factors for Prostate CancerAnnals of Internal Medicine, 1993
- Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1992
- Cancer statistics for African AmericansCA: A Cancer Journal for Clinicians, 1992
- Comparison of the effects of high dose estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: An interim analysis of EORTC-GU group study no. 30865The Journal of Steroid Biochemistry and Molecular Biology, 1990